Trial intelligence / Profile preview

Simvastatin in community-acquired pneumonia

ISRCTN91327214Phase 2Completed

Sponsor
Instituto de Salud Carlos III
Start
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in community-acquired pneumonia (CAP) comparing Simvastatin plus standard care with Placebo plus standard care (2 arms). Primary endpoint: Time to clinical stability. Started Dec 2009; status: completed.

02

Drugs

simvastatin
03

Conditions

community-acquired pneumonia (CAP)

Beyond the preview

Go deeper on ISRCTN91327214.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN91327214.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call